# ADSTILADRIN

NDC: 55566-1050
Generic name: nadofaragene firadenovec-vncg
Labeler / Manufacturer: Ferring Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVESICAL
Marketing started: 20230905

FDA application: BLA125700

## Active ingredients

- NADOFARAGENE FIRADENOVEC: 300000000000 {VP}/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55566-1050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55566-1050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ca20ed4-da4f-463c-ac2a-ccd6ab3774fa